Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17170364 | 1.00 | KDM4E (0.40) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL9890221 | 0.90 | MAPT (0.45) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL21671308 | 0.90 | MAPT (0.47) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL3664059 | 0.90 | MAPT (0.47) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL14679589 | 0.90 | MAPT (0.47) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL10449855 | 0.90 | MAPT (0.47) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL18622771 | 0.90 | EDNRA (0.38) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL9890470 | 0.89 | MAPT (0.44) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL24307158 | 0.89 | MAPT (0.46) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL1636722 | 0.89 | MAPT (0.46) | KDM4EMAPTALDH1A1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| WO-2015156580-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORC3, L1CAM | KDM4E 909/4885MAPT 1029/4885ALDH1A1 610/4885 |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | OR10J3, L1CAM, ICOSLG | KDM4E 953/4885MAPT 1006/4885ALDH1A1 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.